Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies

被引:172
|
作者
Barber, Thomas M. [1 ,2 ]
Hanson, Petra [1 ,2 ]
Weickert, Martin O. [1 ,2 ,3 ]
Franks, Stephen [4 ]
机构
[1] Univ Hosp Coventry & Warwickshire, Warwickshire Inst Study Diabet Endocrinol & Metab, Coventry, W Midlands, England
[2] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England
[3] Coventry Univ, Ctr Appl Biol & Exercise Sci, Coventry, W Midlands, England
[4] Imperial Coll London, Inst Reprod Med, London, England
关键词
Polycystic ovary syndrome; obesity; metabolism; OBSTRUCTIVE SLEEP-APNEA; EXERCISE TRAINING-PROGRAM; HORMONE-BINDING GLOBULIN; INSULIN-RESISTANCE; VISCERAL FAT; ANOVULATORY WOMEN; BODY-COMPOSITION; WEIGHT-LOSS; METABOLIC DYSFUNCTION; CARDIOMETABOLIC RISK;
D O I
10.1177/1179558119874042
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Polycystic ovary syndrome (PCOS) is a common female condition typified by reproductive. hyperandrogenic, and metabolic features. Polycystic ovary syndrome is a genetic condition, exacerbated by obesity. There is a close link between obesity and PCOS based on epidemiological data, and more recently corroborated through genetic studies. There are many mechanisms mediating the effects of weight-gain and obesity on the development of PCOS. The metabolic effects of insulin resistance and steroidogenic and reproductive effects of hyperinsulinaemia are important mechanisms. Adipokine production by subcutaneous and visceral fat appears to play a part in metabolic function, However, given the complexity of PCOS pathogenesis, it is important also to consider possible effects of PCOS on further weightgain. or at least on hampering attempts at weight-loss and maintenance through lifestyle changes. Possible mediators of these effects include changes in energy expenditure, mental ill health. or physical inactivity. In this brief review. we discuss the main mechanisms that underlie the association between obesity and PCOS, from divergent perspectives of weight-gain contributing to development of PCOS and vice versa. We also consider novel management options for women with obesity and PCOS.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] The management of polycystic ovary syndrome
    Bruni, V
    Dei, M
    Pontello, V
    Vangelisti, P
    WOMEN'S HEALTH AND DISEASE: GYNECOLOGIC AND REPRODUCTIVE ISSUES, 2003, 997 : 307 - 321
  • [42] Management of polycystic ovary syndrome
    Yasmin, Ephia
    Balen, Adam H.
    WOMENS HEALTH, 2007, 3 (03) : 355 - 367
  • [43] Is there a role for kisspeptin in pathogenesis of polycystic ovary syndrome?
    Gorkem, Umit
    Togrul, Cihan
    Arslan, Emine
    Oruc, Ayla Sargin
    Duman, Nuriye Buyukkayaci
    GYNECOLOGICAL ENDOCRINOLOGY, 2018, 34 (02) : 157 - 160
  • [44] PATHOGENESIS AND DIAGNOSIS OF POLYCYSTIC-OVARY-SYNDROME
    URDL, W
    DESOYE, G
    GYNAKOLOGISCH-GEBURTSHILFLICHE RUNDSCHAU, 1995, 35 (01): : 12 - 15
  • [45] Current concepts of polycystic ovary syndrome pathogenesis
    Rosenfield, Robert L.
    CURRENT OPINION IN PEDIATRICS, 2020, 32 (05) : 698 - 706
  • [46] Androgens excess and the pathogenesis of polycystic ovary syndrome
    Walters, Kirsty
    CLINICAL ENDOCRINOLOGY, 2018, 89 : 17 - 17
  • [47] Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
    Goodarzi, Mark O.
    Dumesic, Daniel A.
    Chazenbalk, Gregorio
    Azziz, Ricardo
    NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (04) : 219 - 231
  • [48] DNA methylation in the pathogenesis of polycystic ovary syndrome
    Ricardo Vazquez-Martinez, Edgar
    Ines Gomez-Viais, Yadira
    Garcia-Gomez, Elizabeth
    Reyes-Mayoral, Christian
    Reyes-Munoz, Enrique
    Camacho-Arroyo, Ignacio
    Cerbon, Marco
    REPRODUCTION, 2019, 158 (01) : R27 - R40
  • [49] Pathogenesis of polycystic ovary syndrome - the enigma unravels?
    Balen, A
    LANCET, 1999, 354 (9183): : 966 - 967
  • [50] Role of microRNA in the Pathogenesis of Polycystic Ovary Syndrome
    Chen, Zhuo
    Ou, Hanxiao
    Wu, Hongliang
    Wu, Peng
    Mo, Zhongcheng
    DNA AND CELL BIOLOGY, 2019, 38 (08) : 754 - 762